Showing results (1821-1830 of 1,873) with videos related to
Sort By:
Pageof 188
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 27, 2022
Germline Pathogenic Variants Impact Clinicopathology of Advanced Lung CancerSemanti Mukherjee, Chaitanya Bandlamudi, Matthew D Hellmann, et al.Nature Genetics|September 4, 2012
Comprehensive genomic analysis identifies SOX2 as a frequently amplified gene in small-cell lung cancerCharles M Rudin, Steffen Durinck, Eric W Stawiski, et al.Immunity|December 27, 2022
The ectonucleotidase CD39 identifies tumor-reactive CD8+ T cells predictive of immune checkpoint blockade efficacy in human lung cancerAndrew Chow, Fathema Z Uddin, Michael Liu, et al.Cancer Discovery|March 25, 2017
Prospective Comprehensive Molecular Characterization of Lung Adenocarcinomas for Efficient Patient Matching to Approved and Emerging TherapiesEmmet J Jordan, Hyunjae R Kim, Maria E Arcila, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 13, 2020
Circulating Tumor DNA Analysis to Assess Risk of Progression after Long-term Response to PD-(L)1 Blockade in NSCLCMatthew D Hellmann, Barzin Y Nabet, Hira Rizvi, et al.Journal of the National Cancer Institute|November 30, 2018
A Prospective Study of Circulating Tumor DNA to Guide Matched Targeted Therapy in Lung CancersJoshua K Sabari, Michael Offin, Dennis Stephens, et al.Cancer Discovery|April 20, 2026
LIF-Induced Tumor Plasticity Establishes an Immunosuppressive Myeloid Niche in LKB1-Mutant Lung CancerRay Pillai, Ali Rashidfarrokhi, Yuan Hao, et al.Biorxiv : the Preprint Server for Biology|June 12, 2026
Hierarchical classification of immune cell transcriptomes at population-scaleChristopher Beltz, Zekai Qiu, Leon Sadowski, et al.Cancer Cell|June 11, 2021
Tim-4+ cavity-resident macrophages impair anti-tumor CD8+ T cell immunityAndrew Chow, Sara Schad, Michael D Green, et al.BMJ (Clinical Research Ed.)|December 3, 2020
Active conventional treatment and three different biological treatments in early rheumatoid arthritis: phase IV investigator initiated, randomised, observer blinded clinical trialMerete Lund Hetland, Espen A Haavardsholm, Anna Rudin, et al.Pageof 188